I've spent the last couple of weeks in San Francisco ahead of our seed round, and while I've been here I've been sitting in on a lot of investor conversations. Most of them have been what you'd expect - the same panel talking points about picking winners, subject matter expertise, network being everything. But one specific shift kept coming up in every serious conversation, and it's the one I think UK LPs and GPs need to pay real attention to over the next twelve months.

The way sophisticated US LPs are constructing venture portfolios has fundamentally changed. And UK institutional capital, family offices, and sovereign allocators are, by and large, still building for a market that stopped existing about two years ago.

The shift has a name that's now used openly in the US: the barbell.

See below to continue…

Join the waitlist for SoPhy - the networking intelligence engine!

Launching soon. Join the waitlist now.

Sign up here.

Continue…

The panel description I heard put it simply. On one end of the barbell, you have your allocation to what one GP called "the S&P 500 of venture" - the mega-funds like Sequoia, a16z, Founders Fund, General Catalyst, Thrive. These are no longer really venture funds in the traditional sense. They are multi-strategy alternative asset platforms that give you diversified exposure to the small handful of companies (SpaceX, Anthropic, OpenAI, Databricks, Stripe) which are absorbing most of the industry's returns. You allocate to them because you cannot afford not to have exposure to that set of names.

On the other end of the barbell, you have your allocation to genuinely specialist emerging managers - small funds run by subject matter experts with defined edge, unique deal access, and the ability to generate alpha in narrow, non-consensus segments of the market that mega-funds cannot access.

And in the middle - the traditional generalist mid-sized fund, £100M to £300M, sector-agnostic, "we invest across the technology stack" - increasingly nothing.

This is not a subtle repositioning. The data around it is now stark.

If you thought the mega-fund concentration story was overplayed, look at the Q1 2026 numbers.

According to Wellington Management's midyear outlook, the top five managers by capital raised captured 73.1% of all venture commitments in Q1 2026, and the top 15 firms captured 88.5%. PitchBook's data shows funds larger than $1 billion accounted for 71.9% of all capital raised year to date, a significant jump from 34.2% in 2025 and 49% in 2024. Established firms captured 90.9% of fundraising in Q1.

The concentration is happening at the deal side too. Wellington's report highlights that in Q1 the five largest financings accounted for almost $200 billion in investment, pushing the top-five share of total venture deal value to over 70% - the highest recorded level.

What this means in practice is that the middle-band VC fund - the traditional generalist raising a fifth or sixth vehicle at £250M - is now fighting for a shrinking pool of LP dollars while being simultaneously outcompeted at the top by multi-strategy giants and at the bottom by specialists with better deal access. The Wellington team explicitly compares this transition to the buyout industry:

The traditional venture middle is not being disrupted. It is being disintermediated.

The interesting part of the barbell isn't the mega-fund end - most sophisticated LPs already have exposure there. The interesting part is the specialist end, and this is where I think UK LPs are most misaligned with where the actual returns are going to come from.

Cambridge Associates' 2026 outlook makes the case unambiguously. They argue that early-stage venture programs have historically delivered the asset class's best risk-adjusted returns, and they expect that to continue - but they're now specifically advocating for institutional LPs to limit new commitments to "exceptional pre-seed and seed-stage-focused strategies" with a defined edge.

Not generalist early-stage funds. Not "we do everything from pre-seed to Series B" funds. Specialist ones.

Bee Partners, writing about this shift, put it more bluntly:

The panel I sat in on echoed exactly this. Sophisticated US LPs are actively hunting for what they call "emerging manager baskets" - dedicated pools of capital sized as a percentage of their venture allocation and deployed exclusively into specialist emerging managers with genuine edge. The endowments and foundations that stepped back from this segment over the past year, in Bee's words, "are optimising for the appearance of safety at the cost of actual return generation."

Here's the uncomfortable part.

Most UK institutional venture portfolios - the ones I've seen up close through Rare Founders conversations with allocators over the past year - are constructed as spreads across 5 to 15 generalist mid-sized UK and European funds. Some good ones, some average ones, all sitting more or less in the £100M to £400M band, all running broadly similar strategies, all producing broadly similar exposure.

That is the exact shape of portfolio the barbell is designed to eliminate.

To be clear, I'm not saying every UK LP is doing this. There are sovereign funds and university endowments that have been well ahead of this shift, particularly on the emerging manager side. But the median UK institutional venture portfolio is still built as if the top of the market is producing normal returns and the bottom of the market is too risky to touch. Neither is now true.

The mega-funds at the top are absorbing the disproportionate share of the outsized outcomes. The specialists at the bottom are generating the alpha. And the middle band that most UK LPs are still overweight is precisely where returns are compressing hardest.

If you're constructing or evaluating a UK institutional venture portfolio right now, the barbell forces three specific questions that most allocators aren't yet asking with enough seriousness.

First: What is your actual exposure to the top of the barbell?

Most UK LPs assume they have mega-fund exposure through their existing fund investments. In many cases, they don't - they have exposure to funds that were once considered top decile but have been eclipsed by the current mega-fund tier. If your venture programme was built around 2018-2020 relationships, it's worth pressure-testing whether the funds you're re-upping with are still in the segment that's actually capturing returns, or whether they've slipped a tier without anyone noticing.

Second: Do you have a dedicated emerging manager allocation, and is it real?

Cambridge Associates, Wellington and Bee are all now advocating explicitly for institutional emerging manager baskets - not as a nice-to-have but as a structural allocation. If your programme has one line that says "emerging managers, at manager discretion," that isn't a strategy. That's a footnote. The specialists you should be backing require an actual institutional structure, sized appropriately, and staffed with someone whose job is to source and evaluate them.

Third: What are you doing with the middle?

This is the part nobody wants to answer. If a meaningful chunk of your existing venture portfolio is in mid-sized generalist UK and European funds, you have three options:

Cambridge Associates now explicitly recommends secondaries as "a base layer in private market portfolios" precisely to enable this kind of active repositioning.

None of these are theoretical questions. They are the questions the best-in-class US allocators are already answering, in some cases very publicly. UK LPs who don't force themselves to answer them over the next 12 months will find themselves in the position that the middle-band mid-cap funds were in five years ago - technically still in the game, but structurally on the wrong side of where returns are being generated.

Briefly, because this deserves its own piece, the corresponding message for UK GPs is unforgiving. If you are raising a middle-band generalist fund right now, the LP conversation you are having is not the LP conversation you think you are having. The polite meetings you are getting are largely LPs going through the motions with their existing relationships while quietly restructuring their portfolios toward the barbell.

The UK GPs who will thrive over the next five years are the ones who can credibly position themselves as either genuinely differentiated specialists with defined edge - a real thesis, real subject matter expertise, real unique deal access - or as multi-strategy platforms with the scale to compete for mega-fund allocations. The middle position - "we're a strong generalist team with a proven track record" - is no longer a positioning that works.

I've watched UK founders spend the last two years being told that the AI wave was reshaping how companies get built. It's also reshaping how the capital that funds them gets allocated. And the second story is moving just as fast as the first.

Whether UK LPs are ready or not, the barbell is here. The only question left is which end of it your portfolio is on.

✅ Know a UK LP or GP still building their portfolio around the traditional mid-market venture model? Forward this their way. The sooner they restructure toward the barbell, the better positioned they'll be when the next set of returns land.

✅ We also share this list in our founder-focused newsletter. Want to be featured next time? Send me a note.

We've built the ultimate aggregator of all UK startup events.
All the UK's best startup events in one place.

Access here and please share with others!

Tech brands are flooding F1 (34 sponsors in 2026, up 70% from last year). Motorsport is where elite connections happen.

Now enter the room: A private BTCC weekend at Silverstone, 26-27 Sept 2026. Thirty hand-picked family offices, fund GPs, and senior execs only.

What's included:

Not for sale. Invite-only. The right thirty get in.

Register interest here - selected for fit & value to the room.

If you found this roundup useful, share it with another investor who should be in the loop. The bigger our community, the more opportunities we can create together.